UBS Group’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

UBS Group’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-52	Closed	-$3	–	10434
2023 Q3	$3	Buy	+52	New	+$7	﹤0.01%	9337
2023 Q1	–	Sell	-1,438	Closed	-$316	–	10989
2022 Q4	$316	Buy	+1,438	New	+$1.25K	﹤0.01%	10251
2022 Q3	–	Sell	-1,339	Closed	-$1K	–	11294
2022 Q2	$1K	Buy	1,339 +47	+4%	+$49	﹤0.01%	10085
2022 Q1	$2K	Sell	1,292 -935	-42%	-$1.35K	﹤0.01%	9732
2021 Q4	$5K	Buy	+2,227	New	+$6.75K	﹤0.01%	9447

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group's CANO.WS Position: Q4 2023 in Review

UBS Group sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 52 shares — an estimated $3 sold.

UBS Group first reported a position in CANO.WS in Q4 2021 and held it in 5 quarters. The position peaked at $5K in Q4 2021. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

UBS Group reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
UBS Group sold 52 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $3.
UBS Group first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q4 2021 and held it in 5 quarters.
UBS Group's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $5K in Q4 2021.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.